Ascendis Health Limited (JSE:ASC)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 92.00
0.00 (0.00%)
Inactive · Last trade price on Nov 28, 2025
Ascendis Health Income Statement
Financials in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| - | 1,472 | 1,535 | 1,559 | 1,825 | |
Revenue Growth (YoY) | - | -4.13% | -1.54% | -14.57% | -17.14% |
Cost of Revenue | - | 886.86 | 930.91 | 889.4 | 1,066 |
Gross Profit | - | 585.18 | 604.53 | 670.05 | 759.13 |
Selling, General & Admin | 29.62 | 450.48 | 579.98 | 623.77 | 740.79 |
Other Operating Expenses | 9.19 | 115.65 | 166.42 | 113.14 | 142.79 |
Operating Expenses | 38.81 | 577.62 | 749.63 | 736.91 | 883.58 |
Operating Income | -38.81 | 7.56 | -145.1 | -66.86 | -124.45 |
Interest Expense | -8.54 | -12.48 | -62.47 | -453.91 | -1,064 |
Interest & Investment Income | 16.42 | 4.27 | 6.34 | 4.38 | 3.52 |
Currency Exchange Gain (Loss) | - | - | - | - | 7.4 |
Other Non Operating Income (Expenses) | 15.12 | 2.19 | -2.47 | -28.42 | -18.82 |
EBT Excluding Unusual Items | -15.8 | 1.54 | -203.7 | -544.81 | -1,197 |
Impairment of Goodwill | - | - | - | -169.8 | -85.95 |
Gain (Loss) on Sale of Investments | 71.88 | - | - | - | - |
Gain (Loss) on Sale of Assets | -39.98 | 85.2 | 82.76 | 0.28 | 0.45 |
Asset Writedown | - | -28.92 | -128.81 | - | 0 |
Legal Settlements | - | - | - | - | 6.82 |
Other Unusual Items | -7.66 | -17.45 | -34.85 | -81.06 | -270.93 |
Pretax Income | 8.44 | 40.37 | -284.61 | -795.39 | -1,546 |
Income Tax Expense | -2.84 | -1.2 | 1.64 | -37.3 | 108.68 |
Earnings From Continuing Operations | 11.28 | 41.57 | -286.24 | -758.09 | -1,655 |
Earnings From Discontinued Operations | - | 15.72 | 361.56 | 1,208 | 599.9 |
Net Income to Company | 11.28 | 57.29 | 75.32 | 450.15 | -1,055 |
Minority Interest in Earnings | - | - | - | -0.95 | -35.84 |
Net Income | 11.28 | 57.29 | 75.32 | 449.2 | -1,091 |
Preferred Dividends & Other Adjustments | - | 0 | - | - | - |
Net Income to Common | 11.28 | 57.29 | 75.32 | 449.2 | -1,091 |
Net Income Growth | -80.32% | -23.94% | -83.23% | - | - |
Shares Outstanding (Basic) | 626 | 626 | 606 | 480 | 481 |
Shares Outstanding (Diluted) | 626 | 626 | 606 | 480 | 481 |
Shares Change (YoY) | - | 3.27% | 26.35% | -0.35% | 0.83% |
EPS (Basic) | 0.02 | 0.09 | 0.12 | 0.94 | -2.27 |
EPS (Diluted) | 0.02 | 0.09 | 0.12 | 0.94 | -2.27 |
EPS Growth | -80.32% | -26.35% | -86.73% | - | - |
Free Cash Flow | -12.38 | -45.2 | -176.11 | -149.14 | 607.91 |
Free Cash Flow Per Share | -0.02 | -0.07 | -0.29 | -0.31 | 1.26 |
Gross Margin | - | 39.75% | 39.37% | 42.97% | 41.59% |
Operating Margin | - | 0.51% | -9.45% | -4.29% | -6.82% |
Profit Margin | - | 3.89% | 4.91% | 28.80% | -59.76% |
Free Cash Flow Margin | - | -3.07% | -11.47% | -9.56% | 33.30% |
EBITDA | -38.78 | 51.13 | -86.9 | -20.87 | -80.12 |
EBITDA Margin | - | 3.47% | -5.66% | -1.34% | -4.39% |
D&A For EBITDA | 0.03 | 43.57 | 58.2 | 45.98 | 44.33 |
EBIT | -38.81 | 7.56 | -145.1 | -66.86 | -124.45 |
EBIT Margin | - | 0.51% | -9.45% | -4.29% | -6.82% |
Advertising Expenses | - | 53.38 | 51.76 | 32.32 | 65.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.